Is Hypercortisolaemia a Factor in Chronic Fatigue Syndrome?

References

• 1 Feinberg B, Kurzrock R, Talpaz M. et al . A Phase I clinical trial of intravenously administered recombinant tumor necrosis alpha in cancer patients.  J Clin Oncol. 1988;  6 1328-1334
• 2 Orth D N, Kovacs W J. 1998 The adrenal cortex. In: Williams textbook of Endocrinology, 9th Edition. Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Philadelphia; Saunders Publishing Co, Chap. 12
• 3 van Praag H M. Faulty cortisol/serotonin interplay.  Psychiatry Res. 1996;  65 143-157
• 4 Snyder S H. Serotonin sustains serenity.  Nature. 2002;  416 377-380
• 5 McCann S M, Karanath S, Kamat A. et al .1995 Role of cytokines in hypothalamic-pituitary functions. In: Human cytokines, their role in disease and therapy. Aggarwal BB, Puri RK, eds Blackwell Press, Chap. 18
• 6 Fukuda K. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue study group.  Ann Intern Med. 1994;  121 953-959
• 7 Landay A L, Jessop C, Lennette E T, Levy J A. Chronic fatigue syndrome: clinical condition associated with immune activation.  Lancet. 1991;  338 707-712
• 8 Demitrack M A, Dale J K, Strauss S E. et al . Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.  J Clin Endocrinol Metab. 1991;  73 1224-1234
• 9 Komaroff A L. The biology of chronic fatigue syndrome.  Am J Med. 2000;  108 169-171
• 10 Cleare A J, Heap E, Malhi G. et al . Low-dose hydrocortisone in chronic fatigue syndrome; a randomised crossover trial.  Lancet. 1999;  353 455-458
• 11 Caruso I, Sarzi-Puttini P, Cazzola M, Azzolini V. Double-blind study of 5-hydroxytyptophan versus placebo in the treatment of primary fibromyalgia syndrome.  J Internat Med Res. 1990;  18 201-209